참고문헌
- Hung F, Ross F. Conner, Luis P. Villarreal, AIDS in brief. 1999. The biology of AIDS(4th Edition):2-5
- XinZhen Yang, Michael Farzan, Richard Wyatt, and Joseph Sodroski. 2000. Characterization of stable trimers containing complete ectodomains of Humanimmunodeficiency virus type 1 envelope glycoproteins. 2000. Journal of Virology. June. 5716-5725
- Miroslaw K. Gorny, Thomas C. Vancott, Constance Williams, Kathy Revesz, and Susan Zolla-Pazner. 2000. Effects of oligomerization on the epitopes of the Human immunodeficiency virus type 1 envelope glycoproteins. Virology. 267:220-228
- Rogier W. Sanders, Linnea Schiffner, Aditi Master, Francis Kajumo, Yong Guo, Tatjana Dragic, John P. Moore and James M. Binley. 2000. Variable-loopdeletedvariants of the Human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits. Journal of Virology. June. 5091-5100
- Trkola, A., T. Dragic, H. Arthos, J. M. Binley, W, C, Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P.J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interaction between HIV-1 and its co-receptor CCR-5. Nature 384:184-187
- James M. Binley, Rogier W. Sanders, Brian Class, Norbert Schuelke, Aditi Master, Yong guo, Francis Kajumo, Deborah. Anselma, Paul J, Maddon, WillimC. Olson, and John P, Moore. 2000. A recombinant Human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermoleculardisulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion- associated structure. Journal of Virology. Jan. 627-643
- Heilman, C. A., and D. Baltimore. 1998. HIV vaccineswhere are we going? Nature Medicine, 4:532-534
- Letvin, N. L. 1998. Progress in the development of an HIV-1 vaccine. Science 280:1875-1880
- Barnett, S. W., S. Rajasekar, H. Legg, B. Doe, D. H. Fuller, J. R. Haynesm C.M. Walker, and K. S. steimer. 1997. Vaccination with HIV-1 gp120 DNA inducesimmune responses that are boosted by a recombinant gp120 protein subunit. Vaccine 15:869-873
- James D. Watson, Michael Gilman, Jan Witkowski, Mark Zoller, Recombinant HIV proteins may be effective as immunogen for AIDS vaccines. Recombinant DNA (2nd Edition):501-503
- Thomas M. Richardson, JR., Brenda L. Stryjewski, Christopher C. Broder, James A. Hoxie, John R. Mascola, Patricia L. Earl, and Robert W. Doms. 1996.Humoral response to oligomeric Human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology. Feb. 753-762
- N.L. Paul, M. Marsh, J.A. Mckeating, T.F. Schulz, P. Liljestrom, H. Garoff, and R.A. Weiss. 1993. Expression of HIV-1 envelope glycoproteins by Semliki ForestVirus vectors. AIDS RESEARCH AND HUMAN RETROVIRUSES. 9:963-970
- Peter Liljestrom and Henrik Garoff. 1991. A new generation of animal cell expression vectors based on the Semliki Forest Virus replicon. Nature Biotechnology. 9:1356-1361
- Yang, X., L. Florin, M. Farzan, P. Kolchinsky, P. Kwong, J. Sodroski, and R. Wyatt. 2000. Modifications that stabilize human immunodeficiency virus envelopeglycoprotein trimers in solution. Journal of Virology. 74:4746-4754
- Patricia L. Earl, Christopher C. Broder, Deborah Long, Susan A. Lee, Jeffrey Peterson, Sekhar Chakrabarty, Robert W. Doms and Bernard Moss. 1994. Nativeoligomeric Human immunodeficiency virus type 1 envelope glycoprotein eilcits diverse monoclonal antibody reactivities. Journal of Virology. May. 3015-3026
- Abraham Pinter, William J. Honnen, Shermaine A. Tilley, Constantin Bona, Habib Zaghouani, Miroslaw K. Gorny, and Susan Zolla-Pazner. 1989. Oligomericstructure of gp41, the transmembrane protein of Human immunodeficiency virus type 1. Journal of Virology. June. 2674-2679
- Christopher C. Broder, Patricia L. Earl, Deborah Long, Stephen T. Abedon, Bernard Moss, and Robert W. Doms. Antigenic implications of human immunodeficiency virus type 1 glycoprotein quarternary structure: oligomerspecific and -sensitive monoclonal antibodies. 1994. Proc. Natl. Acad. Sci. USA 91:11699-11703
- Patricia L. Earl, Robert W. Doms, and Bernard Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87:648-652
- Pantelis Poumbourios, Walid el Ahmar, Dale A. Mcphee, and Bruce E. Kemp. 1995. Determinants of Human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. Journal of Virology. Feb. 1209-1218
- Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 aminoacids important for CD4 receptor binding. Journal of Virology. 64:5701-5707